Akanda Corporation Announces Completion of F-3 Shelf Registration Statement

Akanda Corporation Announces Completion of F-3 Shelf Registration Statement

newsfile ·  06/14 21:00

London, United Kingdom--(Newsfile Corp. - June 14, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, today announced that it has successfully completed sales of its securities under its existing Form F-3 shelf registration. The shelf registration statement had a $5 million capacity and allowed the Company to raise cash by selling stock and warrants into the open market. Since the F-3 was declared effective on January 29, 2024, the Company raised a total of approximately $4.98 million in gross proceeds pursuant to a series of public offerings.

英國倫敦--(Newsfile Corp. - 2024年6月14日) - 醫療大麻公司Akanda Corp. (納斯達克: AKAN) ("Akanda" 或 "公司") 今日宣佈,在現有的F-3貨架註冊下,已成功完成其證券的銷售。該貨架註冊聲明的規模爲500萬美元,使公司可以通過將股票和認股權證售出到公開市場上來籌集現金。自2024年1月29日F-3生效以來,公司根據一系列公開發行融資總額約498萬美元。

The Interim CEO Katie Field commented, "Akanda has used all of the capacity, essentially maxing out the amount we can raise on our F-3 shelf. We will not raise further funds on this registration statement. Any future registered direct offering will need to be pursuant to a newly filed and effective registration statement which the Company will file in due course."

代理執行長Katie Field評論道:"Akanda已經使用了所有的規模,基本上已將我們在F-3貨架上可以籌集的金額全部用完。我們不會在這一註冊聲明上進一步籌款。將來的任何直接註冊發行都需要根據新提交併經過審核的註冊聲明進行。"

The securities were sold pursuant to a shelf registration statement on Form S-3 that was previously filed with the Securities and Exchange Commission (SEC) and declared effective on January 29, 2024 and is available on the SEC's website located at .


About Akanda Corp.

關於Akanda corp。

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda's portfolio includes CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company's seed-to-patient supply chain also includes partnerships Cellen Life Sciences' Leva Clinic, one of the first fully digital pain clinics in the UK. Akanda also acquired the right to develop a Canadian farming property in British Columbia, including farming land and related operations and licenses. The Company plans to develop THC and cannabinoid (CBD) facilities at this site.

Akanda是一家國際醫用大麻和健康平台公司,旨在通過改善高品質和價格實惠產品的獲得,幫助人們過上更好的生活。Akanda的投資組合包括CanMart,是總部位於英國的全牌照藥品進口商和經銷商,向英國內的藥店和診所提供產品。該公司的種子患者供應鏈還包括與Cellen Life Sciences' Leva Clinic 的合作關係,後者是英國首批全數字化疼痛診所之一。Akanda還獲得了在不列顛哥倫比亞省開發農場和相關經營和許可的權利。公司計劃在該地點開發THC和大麻二酚(CBD)設施。

Connect with Akanda: Email | Website | LinkedIn | Twitter | Instagram


Investor Contact


Cautionary Note Regarding Forward-Looking Information and Statements


This press release contains certain "forward-looking information" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Akanda's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Akanda's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved" and similar expressions and include statements regarding the timing and completion of the proposed offering. Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, product development and sales and growth plans. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Akanda does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.